Diagnostic products were added to Orion’s production schedule in 1968, when Orion’s microbiological department started up the production of Uricult®, intended for the testing of urinary tract infections. The market for the Uricult test and immunology-based products looked promising, and thus the company established the Orion Diagnostica division in 1974.
Orion Diagnostica launched the first product generations of the Hygicult® and Easicult® branded hygiene tests back in the 1970s, along with Dentocult® tests for monitoring oral health. At the beginning of the 1980s, the company rolled out Streptocult® for diagnosing respiratory tract infections and Rotalex®, the world’s first rapid test for rotavirus diagnosis.
In the 2000s, the universally acclaimed QuikRead® system for point-of-care testing became Orion Diagnostica’s major product – particularly QuikRead CRP. The QuikRead go® test system was launched in 2010.
In 2018 Orion Corporation signed an agreement on the sale of all shares in Orion Diagnostica Oy to an investment fund managed by Axcel Management A/S, a leading Nordic private equity investment company.